AP‐Lab: An AI‐Driven Autonomous Pilot‐Scale Platform Bridging Materials Discovery and Industrial Manufacturing
Advanced Science · 2026
DOI: 10.1002/advs.74293 ↗At a glance
Journal article in Advanced Science, 2026. Written by Zhan-Long Wang and 12 co-authors. Institution: Center for Materials Artificial Intelligence, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China. Major MEDLINE topics: Magnetite Nanoparticles, Automation, Laboratory, Nucleic Acids. Cited 3 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key R&D Program of China, Shenzhen Medical Research Fund, Major Project of Guangzhou National Laboratory.
Abstract (original language)
Artificial intelligence (AI) has accelerated materials discovery, yet its translation to industrial manufacturing remains limited due to two critical gaps: the scarcity of proprietary industrial datasets and the absence of application‐oriented benchmarks. To address these challenges, we develop the AP‐Lab, an A I‐Driven Autonomous P ilot‐Scale Lab oratory workstation designed to bridge research and manufacturing. Using magnetic nanoparticles (MNPs) for viral nucleic acids (NAs) extraction as a case study, the AP‐Lab integrates four agent‐controlled systems for user interaction, optimization scheme generation, autonomous synthesis and testing, and data management. By leveraging localized industrial datasets and adopting Polymerase Chain Reaction (PCR) cycle threshold (Ct) values as an application‐specific benchmark, the AP‐Lab achieves rapid optimization of MNPs‐based NAs extraction products at pilot‐scale corresponding to 50,000 tests per batch within three weeks, and enables scale‐up manufacturing of 1 million tests per batch in two months. Compared to conventional manual workflows, the AP‐Lab reduces development timelines from four to six months to three weeks while delivering performance superior to leading commercial products. This work demonstrates a scalable strategy for AI‐driven pilot‐scale production and offers a blueprint for accelerating industrial adoption of advanced materials.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Materials Artificial Intelligence, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
- Shenzhen Small and Medium-sized Pilot Base for AI-driven Material Creation and Manufacture, Shenzhen, Guangdong, China.
- Shenzhen Archean Biotechnology Co., Ltd, Shenzhen, Guangdong, China.
- Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
ORCID profiles: Shengyong Geng, Xue-Feng Yu
Funding
- National Key R&D Program of China
- Shenzhen Medical Research Fund
- Major Project of Guangzhou National Laboratory
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
Cite
APA
Wang, Z. L., Ma, Z., Song, W., Jiang, G., Jiang, B., Jiang, M., Shu, W., Wang, B., Wan, Z., Geng, S., Zhao, Z., Zhou, W., & Yu, X. F. (2026). AP‐Lab: An AI‐Driven Autonomous Pilot‐Scale Platform Bridging Materials Discovery and Industrial Manufacturing. Advanced Science. https://doi.org/10.1002/advs.74293
Vancouver
Wang ZL, Ma Z, Song W, Jiang G, Jiang B, Jiang M, et al. AP‐Lab: An AI‐Driven Autonomous Pilot‐Scale Platform Bridging Materials Discovery and Industrial Manufacturing. Advanced Science. 2026. doi:10.1002/advs.74293
BibTeX
@article{Wang2026,
author = {Wang, Zhan-Long and Ma, Zhifen and Song, Wenxing and Jiang, Guolai and Jiang, Boshi and Jiang, Mingyang and Shu, Weiliang and Wang, Bing and Wan, Zhiyuan and Geng, Shengyong and Zhao, Zhen and Zhou, Wenhua and Yu, Xue-Feng},
title = {AP‐Lab: An AI‐Driven Autonomous Pilot‐Scale Platform Bridging Materials Discovery and Industrial Manufacturing},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.74293}
}
EUVIMED